China In-Vitro Diagnostics (IVD) Market, Company Analysis & Forecast to 2022

Thursday, June 22, 2017 Research News
Email Print This Page Comment bookmark
Font : A-A+

China In-Vitro Diagnostics (IVD) market is likely to more than triple by 2022 from its current level in 2016.

NEW YORK, June 22, 2017 /PRNewswire/ -- China represents one of the largest clinical

laboratory markets in the Asia-Pacific region, and the fastest growing among the top ten IVD country markets. With an aging population, a rapidly growing middle class and a government encouraging preventive care, China IVD market is slated to show substantial growth in the future. Read the full report: http://www.reportlinker.com/p04936611/China-In-Vitro-Diagnostics-IVD-Market-Company-Analysis-Forecast-to.htmlChina's quickly aging population means the country is experiencing an explosion of chronic conditions such as diabetes, heart disease and cancer. All of these conditions can be diagnosed and monitored using IVD products. Further, the average Chinese consumer is now willing and able to pay more for healthcare than a decade years ago. Hence, China has the potential for more dramatic growth in the future. China IVD Market Segment Wise Analysis: Immunoassay is the leading segment in China IVD market. Immunoassay is likely to maintain its dominant position in the forecasting period as well. Clinical Chemistry holds the 2nd position in China IVD market being followed by Molecular Testing. SMBG market accounted for XXX percent market share in 2016. Microbiology and Hematology segments are competing closely with each other to grab maximum share of the pie. China IVD Market Company Analysis: In China IVD market, Roche Diagnostics is the leader with XXX percent market share in 2016. Sysmex Corporation and Mindary Medical are other top two players in the China IVD market. At present, many local players are present in China IVD market and their combined market share was XXX percent in 2016. This is the 2nd edition report on China IVD Market by iGATE RESEARCH. The report titled "China In-Vitro Diagnostics (IVD) Market, Company Analysis & Forecast to 2022" studies in detail the China IVD Market - Application Segment Wise, Company Sales, Registration & Regulatory Status in China IVD & Driving Factors and Challenges for China IVD Market. This 100 Page report with 34 Figures and 3 Tables has been analyzed from 8 View Points: 1) China IVD Market and Forecast (2007 - 2022) 2) China IVD Segment Wise Market & Forecast (2007 - 2022) 3) Development Environment and Regulatory Status in China IVD market 4) Company Wise IVD Sales & Forecast (2010 - 2022) 5) Registration for In Vitro Diagnostic Reagents in China 6) Regulatory History/Status/Trends in China IVD Market 7) Profiles of Select Private Clinical Labs and Diagnostic Services Companies 8) China IVD Industry Drivers & Challenges China IVD Market - 8 Application Segments Covered 1. Clinical Chemistry Market 2. Immunoassay Market 3. Hematology Market 4. Coagulation Market 5. Microbiology Market 6. Molecular Testing Market 7. Self Monitoring of Blood Glucose (SMBG) Market 8. Point of Care Testing (POCT) Market Company Wise IVD Sales & Forecast 1. Roche Diagnostic 2. Abbott Laboratories 3. Sysmex Corporation 4. Mindray Medical International Limited 5. Shanghai Kehua Bio-Engineering Co. Ltd. 6. Others Profiles of Private Clinical Labs and Diagnostic Services Companies in China • Zhejiang Di'an Diagnostics Technology Co., Ltd • ADICON Clinical Laboratories • Guangzhou Kingmed Diagnostics Center Co. Ltd. • Kindstar Global (Privately held) • BGI-Shenzhen (Privately held) • OriGene Technologies (Privately held) Research Methodologies Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc. Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases. Read the full report: http://www.reportlinker.com/p04936611/China-In-Vitro-Diagnostics-IVD-Market-Company-Analysis-Forecast-to.htmlAbout Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.http://www.reportlinker.com __________________________Contact Clare: [email protected] US: (339)-368-6001Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/china-in-vitro-diagnostics-ivd-market-company-analysis--forecast-to-2022-300478480.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store